Transaction · 0000874015-26-000266

Swayze Eric

Swayze Eric, ER, reported a transaction classified as exercise at IONIS PHARMACEUTICALS INC involving 125.000000 shares for an estimated $0.00. Reported holdings after the transaction were 486.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

exerciseSEC transaction code MER
IONSIONIS PHARMACEUTICALS INC
Trade date
Oct 15, 2026
Filing date
Oct 20, 2026
View on SEC Insider profile
Estimated value$0Shares × reported price
Shares traded125$0.00 per share
Holdings after486Indirect · by Son
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

IONS price since this filing

Daily closing prices, with the filing date and available return windows
IONS · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +8.5%1w ago +0.0%1d ago +0.0%
Returns since7d30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
exercise
Code M
Identifier
0000874015-26-000266
Restricted Stock Unit
Transaction date
Oct 15, 2026
Filed Oct 20, 2026, 01:40 AM · 5d delay
Shares
125 sh
$0.00 per share
Estimated value
$0
Computed from shares × price
Holdings after
486 sh
Indirect · by Son

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Derivative Transaction Large Holdings Reduction
Filing-only score

-16 points

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

How this score is calculated
  • derivative_transaction-16 points

    is_derivative = true

    Derivative exercise rows are less discretionary than open-market purchases.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

EVP Research

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award.

  2. F2

    The sale was made pursuant to an automatic sale to cover the required tax withholding obligations pursuant to the 2011 Equity Incentive Plan Restricted Stock Unit Agreement and Grant Notice.

  3. F3

    Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value.

  4. F4

    Restricted Stock Units vest in four equal annual installments. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Compa…

Original filing · 0000874015-26-000266
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

IONS